Company intelligence / Profile preview

avateramedical

Jena, Thüringen, Germany

Ownership: Private
Employees: ~200
Development stage: Other

Overview

The avatera system completed first-in-human surgeries in 2022, received CE mark for minimally invasive laparoscopy (urology and gynecology), and has been introduced at several European clinical sites. Clinical feedback indicated successful and reliable procedural outcomes.

Therapeutic areas: Women's HealthMen's Health
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Tennor Holding B.V.

Beyond the preview

Go deeper on avateramedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on avateramedical.

Explore the full profile